Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-16T15:33:41.955Z Has data issue: false hasContentIssue false

Schizophrenia: A New Approach

(Continued)

Published online by Cambridge University Press:  08 February 2018

H. Osmond
Affiliation:
Saskatchewan Hospital, Weyburn, Saskatchewan
A. Hoffer
Affiliation:
Department of Public Health, University Hospital, Saskatoon, Saskatchewan
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

In the April, 1952 issue of this journal, Osmond and Smythies (47) suggested that schizophrenia might be caused by a defect in adrenaline metabolism. They called this hypothetical adrenaline derivative “M-substance” because they endowed it with mescaline-like psychotomimetic qualities but with an effective potency nearer that of adrenaline or even the hugely powerful LSD-25. They showed that mescaline and adrenaline were sufficiently alike chemically for such an intermediate to be at least imaginable. In addition, they emphasized that the mescaline experience and the more acute and dramatic forms of schizophrenia have many similarities. They hoped that researchers would hunt diligently for our M-substance.

Information

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1959 
Submit a response

eLetters

No eLetters have been published for this article.